Consistent with the microarray results, JAK3 and MCL-1 protein levels were down-regulated in CD8+ T cells isolated from the TC RCC patient when compared to normal donor controls (Fig. 2a–b versus Fig. 2c–d respectively). This evidence concerns the gene JAK3 and renal cell carcinoma.